[go: up one dir, main page]

FI943849A0 - Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond - Google Patents

Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond

Info

Publication number
FI943849A0
FI943849A0 FI943849A FI943849A FI943849A0 FI 943849 A0 FI943849 A0 FI 943849A0 FI 943849 A FI943849 A FI 943849A FI 943849 A FI943849 A FI 943849A FI 943849 A0 FI943849 A0 FI 943849A0
Authority
FI
Finland
Prior art keywords
laongvariga
autoimmuntillstaond
mycobacterium vaccae
foer behandling
treatment
Prior art date
Application number
FI943849A
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Publication of FI943849A0 publication Critical patent/FI943849A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Soil Working Implements (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • External Artificial Organs (AREA)
FI943849A 1992-02-21 1994-08-22 Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond FI943849A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions
PCT/GB1993/000351 WO1993016727A1 (en) 1992-02-21 1993-02-19 Mycobacterium vaccae for treatment of long term autoimmune conditions

Publications (1)

Publication Number Publication Date
FI943849A0 true FI943849A0 (fi) 1994-08-22

Family

ID=10710862

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943849A FI943849A0 (fi) 1992-02-21 1994-08-22 Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond

Country Status (24)

Country Link
US (1) US5885588A (fi)
EP (2) EP0630259B1 (fi)
JP (1) JPH07506093A (fi)
KR (1) KR100275862B1 (fi)
AT (2) ATE192046T1 (fi)
AU (2) AU675421B2 (fi)
BG (1) BG99054A (fi)
BR (1) BR9305946A (fi)
CA (1) CA2130117A1 (fi)
CZ (1) CZ282651B6 (fi)
DE (2) DE69328503T2 (fi)
DK (2) DK0763361T3 (fi)
ES (2) ES2145968T3 (fi)
FI (1) FI943849A0 (fi)
GB (1) GB9203814D0 (fi)
GR (2) GR3024113T3 (fi)
HU (1) HU218347B (fi)
NO (1) NO311169B1 (fi)
NZ (1) NZ249518A (fi)
RO (1) RO117833B1 (fi)
RU (1) RU2124367C1 (fi)
SK (1) SK99994A3 (fi)
UA (1) UA35583C2 (fi)
WO (1) WO1993016727A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
WO1998026790A1 (en) * 1996-12-18 1998-06-25 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the th2 activity of the immune system
RU2137137C1 (ru) * 1997-12-03 1999-09-10 Научно-исследовательский институт по изучению лепры Способ определения m.leprae у больных с регрессом заболевания
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
CN1294632A (zh) * 1997-12-23 2001-05-09 吉尼西斯研究及发展有限公司 得自母牛分枝杆菌的组合物及其使用方法
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
CA2378285A1 (en) * 1999-08-06 2001-02-15 Corixa Corporation Vaccines for the treatment of autoimmune disease
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
EP1684803B1 (en) 2003-11-14 2010-07-07 UCL Business PLC Immune modulator comprising whole cell tsukamurella bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
DK0556248T3 (da) * 1990-11-08 1997-10-27 Univ London Mycobacterium som adjuvans til antigener

Also Published As

Publication number Publication date
ATE192046T1 (de) 2000-05-15
EP0630259A1 (en) 1994-12-28
DK0630259T3 (da) 1997-09-15
AU675421B2 (en) 1997-02-06
JPH07506093A (ja) 1995-07-06
SK99994A3 (en) 1995-05-10
DK0763361T3 (da) 2000-08-07
HUT69941A (en) 1995-09-28
CA2130117A1 (en) 1993-09-02
DE69328503T2 (de) 2000-08-24
GR3033772T3 (en) 2000-10-31
HU218347B (hu) 2000-08-28
GR3024113T3 (en) 1997-10-31
RU2124367C1 (ru) 1999-01-10
AU3637793A (en) 1993-09-13
BG99054A (en) 1995-08-28
RU94045825A (ru) 1997-02-20
ATE151641T1 (de) 1997-05-15
AU7188796A (en) 1997-02-06
US5885588A (en) 1999-03-23
DE69309915D1 (de) 1997-05-22
AU706122B2 (en) 1999-06-10
NO311169B1 (no) 2001-10-22
ES2145968T3 (es) 2000-07-16
EP0763361A3 (en) 1997-03-26
GB9203814D0 (en) 1992-04-08
NO943082D0 (no) 1994-08-22
CZ282651B6 (cs) 1997-08-13
EP0630259B1 (en) 1997-04-16
EP0763361B1 (en) 2000-04-26
WO1993016727A1 (en) 1993-09-02
CZ202394A3 (en) 1995-02-15
HU9402422D0 (en) 1994-10-28
BR9305946A (pt) 1997-10-21
RO117833B1 (ro) 2002-08-30
ES2104131T3 (es) 1997-10-01
KR100275862B1 (ko) 2000-12-15
UA35583C2 (uk) 2001-04-16
DE69309915T2 (de) 1997-07-24
NZ249518A (en) 1997-07-27
KR950700755A (ko) 1995-02-20
NO943082L (no) 1994-10-17
DE69328503D1 (de) 2000-05-31
EP0763361A2 (en) 1997-03-19

Similar Documents

Publication Publication Date Title
FI943849A0 (fi) Mycobacterium vaccae foer behandling av laongvariga autoimmuntillstaond
GB9024320D0 (en) Treatment of uveitis
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
HUT58204A (en) Magnesium-pyridoxale-5'-phosphate-glutaminate for preventing diseases originated from blood-vessel-alternations
FI920356A0 (fi) En biologisk preparation samt dess anvaendning.
CA2023560A1 (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
GR3015716T3 (en) Use of buspirone in sleep apneas.
ATE133334T1 (de) Gammalinolensäure zur herstellung eines medikaments zur verhinderung von wiederverschluss von arterien
Francois et al. Role of iron overload and chelating agents in Yersinia infections on thalassaemia major.
ATE159758T1 (de) Azelluläre impfstoffe

Legal Events

Date Code Title Description
FA Application withdrawn